| Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens (NCT06327568) | European Institute of Oncology | 2022-06-17 |
| Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer (NCT05013216) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-04-11 |
| Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region (NCT05482880) | Maastricht University Medical Center | 2022-02-28 |
| A Study of Tislelizumab, Chemotherapy, and Radiation Therapy for Early-Stage High-Risk ENKTCL (CLCG-2102) (NCT05254899) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-11-10 |
| Needs and Preferences of Patients With Head-neck Cutaneous SCC (NCT06046625) | Maastricht University Medical Center | 2021-11-01 |
| Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer (NCT05120622) | University of British Columbia | 2021-09-01 |
| Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study (NCT04334993) | Israeli Medical Association | 2021-01-01 |
| Three Fraction Radiation to Induce Immuno-Oncologic Response (NCT03978663) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2020-09-02 |
| Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis (NCT04217356) | University Health Network, Toronto | 2020-08-05 |
| A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations (NCT04905329) | Moscow Clinical Scientific Center | 2020-04-28 |
| Prevent Cancer- Greenville (NCT04947098) | Prisma Health-Upstate | 2018-11-08 |
| Adjuvant Radiotherapy Versus Observation After Radical Cystectomy in High Risk Urothelial Bladder Cancer (NCT04740866) | Cairo University | 2018-08-01 |
| Nonmyeloablative Allogeneic Stem Cell Transplant Followed by Bortezomib in High-risk Multiple Myeloma Patients (NCT02308280) | Maisonneuve-Rosemont Hospital | 2014-11-01 |
| Adjunctive Smart Phone Based Smoking Cessation Treatment (NCT03343249) | University of Texas Southwestern Medical Center | 2014-06-01 |
| Neoadjuvant Chemotherapy With Cabazitaxel (NCT01941550) | RWTH Aachen University | 2013-07-01 |
| Fenretinide in Healthy Young Women at Genetic and Familial Risk (NCT01479192) | European Institute of Oncology | 2009-12-01 |